4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-000006
CEO and CFO bought 4,000 shares at $15.19 ($60,760)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-12-29 | Purchase | +4,000 | $15.19 | $60,760 | 2,729,886 | D: show line 1 in the form |
| Open-market purchases · 4,000 sh · avg $15.19 · $60,760 | |||||||
Loading xslF345X03/ownership.xml…